Stockreport

Inventiva resumes Phase 3 study for NASH drug, stock up 6% [Seeking Alpha]

Inventiva S.A. - American Depository Shares  (IVA) 
PDF Phase 3 study for its drug lanifibranor in the treatment of non-alcoholic steatohepatitis, or NASH. Inventiva had paused the trial in February after a patient suffered [Read more]